Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
2.02HKD
1.24 BHKD
3.49 BHKD
359.84 M
About SCICLONE PHARMACEUTICALS (HLDGS) LT
Sector
CEO
Hong Zhao
Headquarters
Shanghai
Website
Employees (FY)
860
ISIN
KYG4271B1023
FIGI
BBG00Z3SLJ93
SciClone Pharmaceuticals (Holdings) Ltd. is an investment holding company which manufactures and markets immune and oncology pharmaceutical products. It focuses on therapeutic areas including oncology and severe infection. The firm's marketed products include, Zadaxin. Its licensed products include Angiomax and Zometa. The company was founded on May 13, 2020 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6600 is 18.00 HKD — it has increased by 0.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SCICLONE PHARMACEUTICALS (HLDGS) LT stocks are traded under the ticker 6600.
SCICLONE PHARMACEUTICALS (HLDGS) LT is going to release the next earnings report on Aug 16, 2024. Keep track of upcoming events with our Earnings Calendar.
6600 stock is 0.44% volatile and has beta coefficient of 0.86. Check out the list of the most volatile stocks — is SCICLONE PHARMACEUTICALS (HLDGS) LT there?
Yes, you can track SCICLONE PHARMACEUTICALS (HLDGS) LT financials in yearly and quarterly reports right on TradingView.
6600 stock has fallen by 0.55% compared to the previous week, the month change is a 23.63% rise, over the last year SCICLONE PHARMACEUTICALS (HLDGS) LT has showed a 60.14% increase.
6600 net income for the last quarter is 531.22 M HKD, while the quarter before that showed 712.71 M HKD of net income which accounts for −25.46% change. Track more SCICLONE PHARMACEUTICALS (HLDGS) LT financial stats to get the full picture.
Today SCICLONE PHARMACEUTICALS (HLDGS) LT has the market capitalization of 10.96 B, it has decreased by 0.11% over the last week.
Yes, 6600 dividends are paid annually. The last dividend per share was 0.39 HKD. As of today, Dividend Yield (TTM)% is 2.17%. Tracking SCICLONE PHARMACEUTICALS (HLDGS) LT dividends might help you take more informed decisions.
Like other stocks, 6600 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SCICLONE PHARMACEUTICALS (HLDGS) LT stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 860.00 employees. See our rating of the largest employees — is SCICLONE PHARMACEUTICALS (HLDGS) LT on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SCICLONE PHARMACEUTICALS (HLDGS) LT technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SCICLONE PHARMACEUTICALS (HLDGS) LT stock shows the strong buy signal. See more of SCICLONE PHARMACEUTICALS (HLDGS) LT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SCICLONE PHARMACEUTICALS (HLDGS) LT future price: according to them, 6600 price has a max estimate of 17.92 HKD and a min estimate of 17.92 HKD. Read a more detailed SCICLONE PHARMACEUTICALS (HLDGS) LT forecast: see what analysts think of SCICLONE PHARMACEUTICALS (HLDGS) LT and suggest that you do with its stocks.